Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Acetylcysteine 2% Oral Solution vs Fluimucil® in Healthy Adults
NCT02688361Phase 1Completed
- Sponsor
- GSK
- Start
- Feb 2016
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of acetylcysteine in respiratory tract infection (RTI) (2 arms), sponsored by GSK. Primary endpoints: Area under the curve from time zero to last sampling time at 3 days and Maximum Plasma Concentration at 3 days. Started Feb 2016; status: completed.
02
Drugs
acetylcysteine
03
Conditions
respiratory tract infection (RTI)
Beyond the preview
Go deeper on NCT02688361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02688361.